Skip to content
PICO Portalanswers from OpenAlex

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

PaperCitations, authors & open-access status

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study is a paper indexed in PICO Portal from OpenAlex.

How many citations does Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study have?

PICO Portalcitation count

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study has 1,246 citations in the OpenAlex counts PICO Portal stores.

When was Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study published?

PICO Portalyear

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study has 2008 year in the PICO Portal index.

What is the open-access status of Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study?

PICO Portaloa status

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study has green oa status in the PICO Portal index.

What is the DOI of Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study?

PICO Portaldoi

The DOI for Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study is on the source record.

What is the PMID of Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study?

PICO Portalpmid

The PMID for Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study is on the source record.

What is the OpenAlex record for Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study?

PICO Portalopenalex

The OpenAlex for Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial